Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Parkinsonism treatment: Part III--Update.

D S Collier1, M J Berg, R W Fincham

  • 1College of Pharmacy, University of Iowa, Iowa City 52242.

The Annals of Pharmacotherapy
|February 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transduction of E13 murine neural precursor cells by non-immunogenic recombinant adeno-associated viruses induces major changes in neuronal phenotype.

Neuroscience·2012
Same author

Prodynorphin processing by rat CNS fractions and purified enzymes: Formation of Dynorphin A 1-8 by sulfhydryl-activated carboxypeptidase and peptidyl dipeptidase.

Neurochemistry international·2010
Same author

Separate metabolic pathways for Leu-enkephalin and Met-enkephalin-Arg(6)-Phe(7) degradation by rat striatal synaptosomal membranes.

Neurochemistry international·2010
Same author

Evidence for conversion of N-Tyr-MIF-1 into MIF-1 by a specific brain aminopeptidase.

Neurochemistry international·2010
Same author

Peritoneal drainage following cholecystectomy: a controlled trial.

Annals of the Royal College of Surgeons of England·2009
Same author

Generic substitution in the treatment of epilepsy: case evidence of breakthrough seizures.

Neurology·2008

New parkinsonism treatments offer hope, including selegiline and pergolide. While vitamin E and fetal transplantation require more research, diet changes can enhance dopamine therapy effectiveness for parkinsonism management.

Area of Science:

  • Neurology
  • Pharmacology
  • Medical Research

Background:

  • Parkinsonism management has evolved with new therapeutic strategies.
  • Understanding recent advancements is crucial for effective clinical practice.

Purpose of the Study:

  • To provide clinicians with an update on recent advances in parkinsonism management.
  • To cover drug therapy, transplantation, and dietary interventions.

Main Methods:

  • Comprehensive literature search of MEDLINE, Index Medicus, and Current Contents (1970-1991).
  • Inclusion of 55 selected articles, emphasizing double-blind, placebo-controlled, and randomized studies.
  • Detailed review and abstraction of critical studies by multiple reviewers.

Main Results:

Related Experiment Videos

  • Selegiline (monoamine oxidase inhibitor type B) shows benefits, particularly in early parkinsonism stages.
  • Pergolide (dopamine agonist) offers an alternative for patients resistant or intolerant to bromocriptine.
  • Vitamin E's antioxidant potential is noted, but clinical data is limited; fetal transplantation remains controversial and requires further research.
  • Diet modification can optimize exogenous dopamine therapy outcomes.

Conclusions:

  • Clinicians need to be aware of emerging parkinsonism management alternatives.
  • This knowledge enables reliable consultation for both professionals and patients.